CX3CR1 and neoplasm: Although neoantigen-specific CD8+ T cells and TILs were enriched in the CX3CR1+ subset in MC38 tumor-bearing mice treated with ICI therapy, it is possible that this subset also contains self-antigen reactive T cells that may have contributed to the increased clonality.